Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
05/06/1998 | EP0839052A1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases |
05/06/1998 | EP0839046A1 Tnf receptor and steroid hormone in a combined therapy |
05/06/1998 | EP0839042A1 Bacterial inhibition with an oligosaccharide compound |
05/06/1998 | EP0839041A1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
05/06/1998 | EP0839040A1 Use of cgmp-phosphodiesterase inhibitors to treat impotence |
05/06/1998 | EP0839039A1 Paroxetine controlled release compositions |
05/06/1998 | EP0839038A1 THERAPEUTIC USE OF d-threo-METHYLPHENIDATE |
05/06/1998 | EP0839037A1 Bioprotectant composition, method of use and extraction process of curcuminoids |
05/06/1998 | EP0839036A1 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls |
05/06/1998 | EP0839035A2 Antifungal agent, compound therefor, process for producing the same |
05/06/1998 | EP0839034A1 Method of treating colonic adenomas |
05/06/1998 | EP0839033A2 Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral |
05/06/1998 | EP0839032A1 Hydroxyl ions as unique therapeutic agents and compounds that modulate ions, compounds |
05/06/1998 | EP0839031A1 Use of a non-steroidal anti-inflammatory drug for topical and systemic treatment of acute and chronic polypoid rhinosinusitis |
05/06/1998 | EP0839029A1 Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules |
05/06/1998 | EP0839028A2 Pharmaceutical compositions |
05/06/1998 | EP0839026A1 Polyether block copolymer micellar compositions for targeting biological agents |
05/06/1998 | EP0839024A1 Ionophore antibiotic formulations |
05/06/1998 | EP0817636A4 Cinnamoyl-c-glycoside chromone isolated from aloe barbadensis |
05/06/1998 | EP0788364A4 Treatment of urogenital cancer with boron neutron capture therapy |
05/06/1998 | EP0746265A4 -i(IN SITU) DISSOLUTION OF ALGINATE COATINGS OF BIOLOGICAL TISSUE TRANSPLANTS |
05/06/1998 | EP0745072B1 4-amino derivatives of 5-substituted mycophenolic acid |
05/06/1998 | EP0743842A4 Drug-containing adhesive composite transdermal delivery device |
05/06/1998 | EP0742790A4 Substituted purines and oligonucleotide cross-linking |
05/06/1998 | EP0740652B1 Metalloproteinase inhibitors |
05/06/1998 | EP0738270B1 Dihydro pyrazolopyrroles |
05/06/1998 | EP0737062B1 Water-in-oil lotion containing a corticosteroid |
05/06/1998 | EP0733214B1 Dense microsphere components derived from mammalian brain tissue and antibodies thereto |
05/06/1998 | EP0730577B1 26,28-methylene-1alpha,25-dihydroxyvitamin d2 compounds |
05/06/1998 | EP0710242B1 Antiparasitic agents |
05/06/1998 | EP0707570B1 Isoquinoline derivatives as therapeutic agents |
05/06/1998 | EP0705254B1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
05/06/1998 | EP0671908B1 Pharmaceutical compositions comprising 5-ht 1? receptor agonists and absorption enhancers |
05/06/1998 | EP0438519B1 Therapeutic peptides |
05/06/1998 | CN1181084A Tricyclic benzazepine vasopression antagonists |
05/06/1998 | CN1181083A Novel intermediates and process for the manufacture of camptothecin derivatives (CPT-11| and related compounds |
05/06/1998 | CN1181081A Anellated 'beta' -carbolines |
05/06/1998 | CN1181079A Novel triazolones as apolipoprotein-B synthesis inhibitors |
05/06/1998 | CN1181077A Benzopyran-containing compounds and method for their use |
05/06/1998 | CN1181075A Substituted isoxazoles for the treatment of inflammation |
05/06/1998 | CN1181073A 1, 3 -dihydro -2H -imidazol -2 -one derivatives having PDEIV and cytokinin inhibiting activity |
05/06/1998 | CN1181072A 1, 3 -dihydro -1 -(phenylalkyl) -2H -imdiazol- 2 -one derivatives having PDEIV and cytokine activity |
05/06/1998 | CN1181071A 1, 3-dihydro -1 -(phonylalkenyl) -2H -imidazol -2 -one derivatives having PDEIV and cytokine inhibiting activity |
05/06/1998 | CN1181070A Bicyclic isothiourea derivatives useful in therapy |
05/06/1998 | CN1181069A 5 -(4 -subst. -piperidinyl -1) -3 -aryl -pentanoic acid derivatives as tachykinin receptor antagonist |
05/06/1998 | CN1181066A Arylsulfonylamino hydroxamic acid derivatives |
05/06/1998 | CN1181064A O-carbamoyl-phenylalaninol having substituent at benzene ring ,its pharmaceutically useful salts and method for preparing the same |
05/06/1998 | CN1181060A Alk(En)yl dicarboxylic acid bisesters, their use and method for preparing them |
05/06/1998 | CN1181021A Method and compositions for regulation of CD28 expression |
05/06/1998 | CN1181019A Combination compositions containing benazepril or beazeprilat and valsartan |
05/06/1998 | CN1181016A Use of hyaluronic acid for the treatment of interstitial cystitis |
05/06/1998 | CN1181015A Reduction of infarct volume using citicoline |
05/06/1998 | CN1181014A A pharmaceutical composition containing N-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers |
05/06/1998 | CN1181013A Anti-virus triaza compounds |
05/06/1998 | CN1181012A Method of lessening the rish of non-vertebral bone fractures |
05/06/1998 | CN1181011A Combined hormonal contraception pharmaceutical perparation |
05/06/1998 | CN1181010A A Pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers |
05/06/1998 | CN1181009A A Pharmaceutical composition N-chlorophenylcarbamates, N-chlorophenylthiocarbamates and N-phosphonoglycine derwatives for inhibiting the growth of cancers and viruses in mammals |
05/06/1998 | CN1181008A Method of lessening the risk of vertebral fractures |
05/06/1998 | CN1181007A Preparation for absorbing transmission from skin |
05/06/1998 | CN1180711A Thioether conjugates |
05/06/1998 | CN1180698A Substituted dismino -1, 3, 5-triazine derivatives |
05/06/1998 | CN1180570A High polymer antineoplastic guide medicine and preparation method thereof |
05/06/1998 | CN1180521A Medicinal composite containing megestrol acetate |
05/06/1998 | CN1180520A Compound capsule for treating red swollen and heat-evil due to wind-cold-dampness |
05/06/1998 | CN1038227C Method for manufacture film forming agent for treatment on human body tissue |
05/05/1998 | US5748828 Color separating backlight |
05/05/1998 | US5747664 N-Phenyl-2-cyano-3-hydroxycrotonamide derivatives |
05/05/1998 | US5747663 Process for the depletion or removal of endotoxins |
05/05/1998 | US5747659 Increased egg lay; fertility agents |
05/05/1998 | US5747655 Nerve cells, geonomes dna sequences and amino acid sequences |
05/05/1998 | US5747646 Polyethylene-protein conjugates |
05/05/1998 | US5747642 Monomeric insulin analog formulations |
05/05/1998 | US5747639 Use of hydrophobic interaction chromatography to purify polyethylene glycols |
05/05/1998 | US5747545 Method of preventing NMDA receptor complex-mediated Neuronal damage |
05/05/1998 | US5747544 Method of using pure 3R-3'R stereoisomer of zeaxanthin to treat or prevent retinal degeneration in humans |
05/05/1998 | US5747543 Anticarcinogenic agents and antihistamines |
05/05/1998 | US5747541 Substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic agent, and medicament comprising them |
05/05/1998 | US5747539 Fluorine-containing benzoylguanidines |
05/05/1998 | US5747538 Glucopyranoside for synthesis of collagen |
05/05/1998 | US5747537 Method of inhibiting parasitic activity |
05/05/1998 | US5747536 Atheriosclerosis and cardiovascular disorders |
05/05/1998 | US5747535 Selective thrombin inhibitors |
05/05/1998 | US5747534 Lobaplatin trihydrate |
05/05/1998 | US5747533 Use of ω-3-fatty acids |
05/05/1998 | US5747532 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
05/05/1998 | US5747530 Aromatic dibenzofuran compounds and pharmaceutical/cosmetic compositions comprised thereof |
05/05/1998 | US5747529 Antitumor agents |
05/05/1998 | US5747528 Chroman derivatives as anti-oxidants |
05/05/1998 | US5747527 Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes |
05/05/1998 | US5747526 Anti-HIV /Aids Chemo(C)-, immuno(I)-, or ci-therapy using tur (or related compounds) and/or NVA (or EPV) |
05/05/1998 | US5747525 Medicinal thiophene compounds |
05/05/1998 | US5747524 Cannabinoid receptor antagonists |
05/05/1998 | US5747522 Anticoagulants; antiinflammatory agents; antitumor agents |
05/05/1998 | US5747520 Azatoxin derivatives; antitumor and anticarcinogenic agents |
05/05/1998 | US5747517 Benzylidene rhodanines |
05/05/1998 | US5747515 Heterocyclic compounds and compositions having nevropharmacological potential |
05/05/1998 | US5747514 Metalloproteinase inhibitors |
05/05/1998 | US5747513 Hypotensive agents, heart failure and cerebrovascular insufficiency |
05/05/1998 | US5747512 Use of cotinine to alleviate tobacco withdrawal syndrome |